Retatrutide 20mg
$ 229.99
Retatrutide is a GGG tri-agonist that simultaneously targets GLP-1, GIP, and glucagon receptors, offering a multifaceted approach to metabolic research. By activating all three pathways, it provides a broader mechanism of action compared to traditional GLP-1 agonists, making it a promising candidate for studies focused on weight management, glucose regulation, and metabolic health.
Related products
-
Cagrilintide 10mg
$ 184.99 -
Retatrutide 10mg
$ 139.99 -
Retatrutide 30mg
$ 289.99 -
Semaglutide 10mg
$ 129.99 -
Super Shred 153.4mg
$ 99.99